[1] Ch.P (2015) Vol Ⅰ (中国药典2020年版.一部). 2020:163-164.
[2] CHAI W S, YANG F, YU H J, et al. Analysis of chemical constituents of radix polygalae by UPLC/ESI-Q-TOF MS. Tianjin J Tradit Chin Med(天津中医药),2018,35(1):60-64.
[3] YANG H C, ZHANG H Y, ZHANG Y X, et al. Current status of stem cell therapy for Alzheimer's disease. J Hainan Med Univ(海南医学院学报), 2020, 26(11):876-880.
[4] ALZHEIMER'S A.2020 Alzheimer's disease facts and figures. Alzheimer's Dement, 2020, 16(3):391-460.
[5] CHRISTIANE R, RICHARD M. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol, 2014, 88(4):640-651.
[6] WANG Y Q, LIANG J H, JIA R X, et al. Alzheimer disease in China (2015-2050) estimated usin g the 1% population sampling survey in 2015. Chin J Alzheimer's Dis Relat Disord(阿尔茨海默病及相关病杂志), 2019, 2(1):289-298.
[7] SOYON H, VICTORIA F. B-G, BIANCA M. N, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science, 2016, 352(6286):712-716.
[8] ISHIZUKA Y, HANAMURA K. Drebrin in Alzheimer's Disease. Adv Exp Med Bio, 2017, 1006(1):203-223.
[9] PHILLIP R. GORDON-W. The role of the drebrin/EB3/Cdk5 pathway in dendritic spine plasticity, implications for Alzheimer's disease. Brain Res Bull, 2016, 126(3):293-299.
[10] NI J X, CHEN M S, LIN Y H. Research progress on triterpenoid saponins from Polygalaceae and their biological activities. J Chin Med Mat(中药材), 2011, 34(2):317-319.
[11] ZHANG T Z, RONG W W, LI Q, et al. Research progress on Polygalae Radix. Chin Tradit Herb Drugs(中草药), 2016, 47(13):2381-2389.
[12] FU J, ZHANG D M, CHEN R Y. Advances in studies on saponins and their pharmacological activities in plants of Polygala L. Chin Tradit Herb Drugs(中草药), 2006, 37(1):144-146.
[13] SEIICHI S, JUNZO S. Studies on the constituents of the root of polygala tenuifolia WILLDENOW. II. on the structures of onjisaponins A, B and E. Chem Pharm Bull, 1982, 30(3):810-821.
[14] SEIICHI S, JUNZO S. Studies on the constituents of the root of polygala tenuifolia WILLDENOW. I. isolation of saponins and the structures of onjisaponins G and F. Chem Pharm Bull, 1981, 29(9):2431-2441.
[15] LI C J, YANG J Z, YU S S, et al. Triterpenoid saponins and oligosaccharides from the roots of polygala tenuifolia willd. Chin J Nat Med(中国天然药物), 2011, 9(5):321-328.
[16] LIU J Y, YANG X D, HE J M, et al. Structure analysis of triterpene saponins in Polygala tenuifolia by electrospray ionization ion trap multiple-stage mass spectrometry. J Mass Spectrom, 2007, 42(7):861-873.
[17] SONG Y L, ZENG K W, SHI X T, et al. Sibiricasaponins A-E, five new triterpenoid saponins from the aerial parts of Polygala sibirica L. Fitoterapia, 2013, 126(84):295-301.
[18] WANG X Y, LIU C X, ZHOU J L, et al. Research advances in the chemical constituents and pharmacological effects of Polygalae Radix(PR), a traditional Chinese medicine, and a predictive analysis of potential PR quality-makers. J Inter Pharm Res(国际药学研究杂志), 2020, 47(7):483-495,513.
[19] YANG X D, ZHANG L J, LIANG B, et al. Oligosaccharide esters isolated from plants of Polygalaceae. Chin Tradit Herb Drugs(中草药), 2002, 33(10):92-96.
[20] TOSHIO M, YUKIKO I, AKIRA U. Tenuifolioses A-F, oligosaccharide multi-esters from the roots of polygala tenuifolia willd. Chem Pharm Bull, 1991, 39(11):3082-3084.
[21] TOSHIO M, YUKIKO I, AKIRA U. Tenuifolioses G-P, oligosaccharide multi-esters from the roots of polygala tenuifolia WILLD. Chem Pharm Bull, 1992, 40(10):2741-2748.
[22] LI P, YAN M, LI P Y. Isolation and identification of the chemical constituents from Polygala tenuifolia Wild. Chin J Med Chem(中国药物化学杂志), 2005, 15(1):42-45.
[23] JIANG Y Y, DUAN Y Y, LIU Y, et al. Isolation and structure identification of chemical constituent of Yuanzhi (Radix Polygalae). J Beijing Univ Tradit Chin Med(北京中医药大学学报), 2011, 34(2):122-125.
[24] YUKINOBU I, KO S, MINORU O, et al. Four new phenolic glycos ides from polygala tenuifolia. Chem Pharm Bull, 1991, 39(10):2600-2605.
[25] TU H H, LIU P, MA L, et al. Study on antidepressant components of sucrose ester from Polygala tenuifolia. China J Chin Mater Med(中国中药杂志), 2008, 33(11):1278-1280.
[26] MIYASE T, NOGUCHI H, CHEN X M. Sucrose esters and xanthone C-glycos ides from the roots of Polygala sibirica. J Nat Prod, 1999, 62(7):993-996.
[27] JIANG Y, TU P F. Progress in studies on Polygala tenuifolia. Chin Tradit Herb Drugs (中草药), 2001, 32 (8):90-92.
[28] JIANG Y, TU P F. Studies on the chemical constituents in root bark of Polygala tenuifolia (Ⅱ). China J Chin Mat Med(中国中药杂志), 2004, 29(8):38-40.
[29] WANG Y P, YANG J S, ZHANG Y M, et al. Studies on the chemical constituents of radix polygonae. Chin Tradit Herb Drugs(中草药), 2005, 36 (9):15-17.
[30] HU Y, LIAO H B, DAI H G, LIU P, et al. Antidepressant-like effects of 3, 6'-disin apoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats. Neurochem Int, 2010, 56(3):461-465.
[31] LIU D W, KANG L P, MA B P. Chemical constituents and pharmacological activities of Polygala tenuifolia Willd.:research advances. J Inter Pharm Res(国际药学研究杂志), 2012, 39(1):32-36,44.
[32] TAN P, LIU Y L. Plant ketone glucos ide compounds. Nat Prod Res Dev(天然产物研究与开发), 1995,7(1):45-54.
[33] LIU C, MA H Y. Overview in studies on traditional chinese medicine polygala. J Hebei Agric Sci(河北农业科学), 2014, 18(5):75-81.
[34] YANG X D, XU L Z, YANG S L. Advances in the research of chemistry and pharmacology of xanthones extracted from polygala Ⅰ. Nat Prod Res Dev(天然产物研究与开发), 2000, 12(5):88-94.
[35] XU L L, LI C J, YANG J Z, et al. Chemical Constituents of Polygala tenuifolia Root. J Chin Med Mater(中药材), 2014, 37(9):1594-1596.
[36] JIANG Y, ZHANG W, TU P F, et al. Xanthone glycos ides from Polygala tenuifolia and their conformational analyses. J Nat Prod, 2005, 68(6):875-879.
[37] MIYASE T, NOGUCHI H, CHEN X M. Sucrose esters and xanthone C-glycos ides from the roots of Polygala sibirica. J Nat Prod, 1999, 62(7):993-996.
[38] JIANG Y T, TU P F. Xanthone O-glycos ides from Polygala tenuifolia. Phytochemistry, 2002, 60(8):813-816.
[39] ZHOU Y H, ZHANG S Y, GUO Q, et al. Chemical investigation of the roots of Polygala sibirica L. Chin J Nat Med(中国天然药物), 2014, 12(3):225-228.
[40] JIANG Y, LIU L, TU P F. Studies on the chemical constituents in root bark of Polygala tenuifolia Ⅲ. Chin J Nat Med(中国天然药物), 2003, 1 (3):15-18.
[41] JIN B Y, PIAO Z Y. Study on the alkaloids of Polygala. China J Chin Mat Med(中国中药杂志), 1993, 18(11):675-677.
[42] SUN X F, SHI SU QIN, YANG G H. Composition analysis of fatty oils in Radix Polygalae. J Chin Med Mater(中药材), 2000, 23(1):35-37.
[43] SONG Y L, JIANG Y, ZHOU S X, et al. Studies on the chemical constituents of the aboveground parts of polygalaceae ovalium. Chin Tradit Herb Drugs(中草药), 2010, 41(1):27-29.
[44] ZHAO Y S, YAN Z Y, LI Z L, et al. The determination of polysaccharide's content in the different polygala tenuifolia willd resources from Shanxi. Lishizhen Med Mat Med Res(时珍国医国药), 2005, 16(9):867-868.
[45] WANG Q Q, LV J L, HU Y C, et al. Pathogenesis and new therapeutic drugs of Alzheimer disease. Chin Pharm J(中国药学杂志), 2020, 55(23):1939-1947.
[46] GUO F F, ZHU Z. New Alzheimer's drug-memantine. Chin Pharm J(中国药学杂志), 2006, 41(23):1837-1838.
[47] ZHANG H, ZHENG Y. β Amyloid hypothesis in Alzheimer's disease: pathogenesis, prevention, and management. Acta Acad Med Sin(中国医学科学院学报), 2019, 41(5):702-708.
[48] LI K, WEI Q, LIU F F, et al. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations. Mol Neurobiol, 2018, 55(4):3021-3032.
[49] LV J, JIA H, JIANG Y, et al. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid-beta sec retion in vitro. Acta Physiol (Oxf), 2009, 196(4):419-425.
[50] WANG L, JIN G F, YU H H, et al. Protection effect of tenuifolin isolated from polygala tenuifolia willd roots on Neuronal Apoptosis and learning and memory deficits in mice with Alzheimer's disease. Food Funct, 2019, 10(11):7457-7460.
[51] CHEN Q, CHEN Y Q, YE H Y, et al. The mechanism of tenuigenin for eliminating waste product accumulation in cerebral neurons of Alzheimer's disease rats via ubiquitin-proteasome pathway. Chin J Integr Tradit West Med(中国中西医结合杂志), 2015, 35(3):327-332.
[52] MURRAY D.W, A H. LOCKWOOD, HWO S Y, et al. A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA, 1975, 72(5):1858-1862.
[53] GAO Y, TAN L, YU J T, et al. Tau in Alzheimer's Disease: mechanisms and therapeutic strategies. Curr Alzheimer Res, 2018, 15(3):283-300.
[54] NISBET R M, GÖTZ J. Amyloid-β and tau in Alzheimer's disease: novel pathomechanisms and non-pharmacological treatment strategies. J Alzheimer's Dis, 2018, 64(Suppl 1):S517-S527
[55] PîRSCOVEANU D F V, PIRICI I, TUDORIC V, et al. Tau protein in neurodegenerative diseases-a review. Rom J Morphol Embryo, 2017, 58(4):1141-1150.
[56] AKAN I, OLIVER-VAN S S, BOND M R, et al. Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration. J Neurochem, 2018, 144(1):7-34.
[57] CHEN Y J, HUANG X B, CHEN W Q, et al. Experimental study of tenuigenin regulating phosphorylation of tau protein. Chin J Inf Tradit Chin Med(中国中医药信息杂志), 2012, 19(9):45-47.
[58] CHEN K L, CHEN Q, LIU W, et al. Effect of tenuigenin on tau protein phosphorylation at Ser396 site in neurons of AD rats induced by Aβ1-40. Chin J Pathophysiol(中国病理生理杂志), 2012, 28(9):1605-1609.
[59] CHEN Y J, HUANG X B, CHEN W Q, et al. Tenuigenin promotes proliferation and differentiation of hippocampal neural stem cells. Neurochem Res, 2012, 37(4):771-777.
[60] LIAO D Q, ZHANG L C, LAN Y, et al. Protective effect of senegenin on the injury of rat hippocampal neural stem cells induced by oxygen-glucos e deprivation/reoxygenation culture in vitro. Chin J Inf Tradit Chin Med(中国中医药信息杂志), 2019, 34(7):2990-2993.
[61] XIE P J, HAO Y W, GUO J, et al. Yuanzhi powder regulates phosphorylation of tau protein through PI3K/AKT/GSK-3β pathway in alzheimer's disease model rats. Chin Arch Tradit Chin Med(中国病理生理杂志), 2020, 38(11):167-170,280-286.
[62] PI T, LIANG Y Q, OU W L R, et al. Senegenin protects against lipopolysaccharide-induced neurite toxicity in a nerve cell model. Chin J Compar Med(中国比较医学杂志), 2020, 30(11):52-58.
[63] WANG X K, LI M, CAO Y Z. et al Tenuigenin inhibits LPS-induced infla mmatory responses in microglia via activating the Nrf2-mediated HO-1 signaling pathway. Eur J Pharm, 2017, 809:196-202.
[64] KIM K S, LEE D S, BAE G S, et al. The inhibition of JNK MAPK and NF-κB signaling by tenuifoliside A isolated from Polygala tenuifolia in lipopolysaccharide-induced macrophages is associated with its anti-infla mmatory effect. Eur J Pharm, 2013, 721(1-3):267-276.
[65] HABIB Y, YUNES P, BEHJAT J, et al. The underlying role of oxidative stress in neurodegeneration: a mechanistic review. CNS Neurol Disord-Dr, 2018, 17(3):207-215.
[66] HUANG X B, CHEN Y J, CHEN W Q, et al. Neuroprotective effects of tenuigenin on neurobehavior, oxidative stress, and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats. Brain Circ, 2018, 4(1):24-32.
[67] WANG L, JIN G F, YU H H, et al. Protective effect of Tenuifolin against Alzheimer's disease. Neurosci Lett, 2019, 705(26):195-201.
[68] SANG X X, YANG Y, FANG F. Research progress in pharmacological activities of oligosaccharide esters from polygala tenuifolia. Chin Pharm J (中国药学杂志), 2017, 52(18):1576-1579.
[69] ZHENG R J. The transport removals and regulation of Teuigenin on Beta-Amyoid-induced PC12 cells function and cell cycle. Guangzhou: Guangzhou Pharm Univ, 2016.
[70] SANG X X, YANG Y, TANG X L, et al. Effects of oligosaccharide esters of polygala tenuifolia on the injury of human neuroblastoma SH-SY5Y cells induced by Aβ25-35 fragment. Chin Pharm J (中国药学杂志), 2018, 53(11):876-881.
[71] SHIN K Y, WON B Y, HEO C, et al. BT-11 improves stress-induced memory impairments through increment of glucos e utilization and total neural cell adhesion molecule levels in rat brains. J Neurosci Res, 2009, 87(1):260-268.
[72] GUO C R, SHEN J Y, MENG Z Q, et al. Neuroprotective effects of polygalacic acid on scopolamine-induced memory deficits in mice. Phytomed, 2016, 23(2):149-155.
[73] WEI X, JIN F H, YU H Y, et al. Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory. Acta Pharmacol Sin(中国药理学报), 2009, 30(9):1211-1219.
[74] REEJU M, CHIRANJIVI T, WANG N, et al. Identification of polygala saponins and their metabolites in vivo from ethanol extract of kaixinsan. Chin J Exper Tradit Med Form(中国实验方剂学杂志), 2017, 23(19):118-123.
[75] ZHU Z P, WANG J, HUANG L H, et al. Research on chemical constituents and metabolic processes of Yuanzhi saponin. Pharm Clin Chin Mater Med(中药与临床), 2016, 7(4):61-65.
[76] FENG G F. Study on the material basis of Ding-Zhi-Xiao-Wan prescription in the treatment of Alzheimer's disease in vitro and in vitro based on mass spectrometry. Beijing:Univ Sci Tech Chin, 2019.
[77] WANG Z X, HU G H. Research overview of TCM treatment of Alzheimer's disease. Hunan J Tradit Chin Med(湖南中医杂志), 2020, 36(5):155-157.